Cargando…
Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
Multiple myeloma (MM) is a hematologic malignancy characterized by the accumulation of bone marrow (BM) clonal plasma cells, which are strictly dependent on the microenvironment. Despite the improvement of MM survival with the use of new drugs, MM patients still relapse and become always refractory...
Autores principales: | Marchica, Valentina, Costa, Federica, Donofrio, Gaetano, Giuliani, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956262/ https://www.ncbi.nlm.nih.gov/pubmed/33668361 http://dx.doi.org/10.3390/ijms22052259 |
Ejemplares similares
-
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
por: Marchica, Valentina, et al.
Publicado: (2020) -
Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma
por: Meyers, Daniel E., et al.
Publicado: (2017) -
Oncolytic Virotherapy for Multiple Myeloma: Past, Present, and Future
por: Thirukkumaran, Chandini M., et al.
Publicado: (2011) -
PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-Suppression
por: Costa, Federica, et al.
Publicado: (2021) -
Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
por: Qi, Zhongbing, et al.
Publicado: (2022)